Process for suppressing the tremor of parkinson's syndrome
    2.
    发明授权
    Process for suppressing the tremor of parkinson's syndrome 失效
    抑制帕金森综合症患者的方法

    公开(公告)号:US3743732A

    公开(公告)日:1973-07-03

    申请号:US3743732D

    申请日:1972-02-14

    Applicant: MILES LAB

    Inventor: RODRIGUEZ R

    CPC classification number: C07D215/38

    Abstract: THE TREMOR OF PARKINSONS''S SYNDROME IN MAMMALS IS SUPPRESSED BY THE ADMINSTRATION OF A COMPIUND OF THE FORMULA:

    2-(4-R-PIPERAZIN-1-YL)-QUINOLINE

    IN WHICH R IS A MEMBER SELECTED FROM THE GROUP CONSISTING OF H AND CH3, AND NONTOXIC PHARMACOLOGICALLY ACCEPTABLE ACID ADDITION SALTS THEREOF. THESE COMPOUNDS MAY BE UTILIZED IN CONJUNCTION WITH PHARMACEUTICALLY ACCEPTABLE VEHICLES THEREFOR.

    1-(2-pyridyl)piperazine and levodopa composition
    3.
    发明授权
    1-(2-pyridyl)piperazine and levodopa composition 失效
    1-(2-吡啶基)哌嗪和左旋多巴组合物

    公开(公告)号:US3790674A

    公开(公告)日:1974-02-05

    申请号:US3790674D

    申请日:1972-12-21

    Applicant: MILES LAB

    Inventor: RODRIGUEZ R

    CPC classification number: A61K31/495 A61K31/135

    Abstract: A COMPOSITION COMPRISING 1-(2-PYRIDYL)PIPERAZINE AND LEVODOPA IN A RESPECTIVE WEIGHT RATIO OF FROM 1:320 TO 1:20 CONTROLS TREMO SYMPTOMATIC OF PARKINSONISM IN MAMMALS. PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALTS OF 1-(2-PYRIDYL) PIPERAZINE CAN BE SUBSTITUTED IN LIEU OF THE PARENT COMPOUND IN THE COMPOSITION.

    Method of treating depression with 1-(2-pyridyl)piperazine
    5.
    发明授权
    Method of treating depression with 1-(2-pyridyl)piperazine 失效
    用1-(2-吡啶基)哌嗪处理沉淀的方法

    公开(公告)号:US3773951A

    公开(公告)日:1973-11-20

    申请号:US3773951D

    申请日:1972-12-21

    Applicant: MILES LAB

    Inventor: RODRIGUEZ R

    CPC classification number: A61K31/495

    Abstract: ADMINISTRATION OF 1-(2-PYRIDYL)PIPERAZINE OR A PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT THEREOF IS DISCLOSED AS A CHEMOTHERAPEUTIC METHOD OF TREATING MANIFESTATIONS OF DEPRESSION IN EXPERIMENTAL MAMMALS. DAILY DOSES RANGING FROM 2 MG./KG. TO 60 MG./KG. PER DAY ARE CONSIDERED EFFECTIVE.

Patent Agency Ranking